Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 11/20 | 0.85 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | HTR7 | P34969 | 1/20 | 0.64 |
| ▸ | HTR6 | P50406 | 1/20 | 0.64 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16120999 | 1.00 | ADORA2B (0.85) | ADORA2BRXFP1MAPK1LMNAMAPT | |
| SCHEMBL16121000 | 1.00 | ADORA2B (0.85) | ADORA2BRXFP1MAPK1LMNAMAPT | |
| SCHEMBL16120982 | 1.00 | ADORA2B (0.85) | ADORA2BRXFP1MAPK1LMNAMAPT | |
| SCHEMBL16120983 | 1.00 | ADORA2B (0.85) | ADORA2BRXFP1MAPK1LMNAMAPT | |
| SCHEMBL19969384 | 1.00 | ADORA2B (0.85) | ADORA2BRXFP1MAPK1LMNAMAPT | |
| SCHEMBL16120975 | 0.98 | ADORA2B (0.88) | ADORA2BRXFP1MAPK1LMNAMAPT | |
| SCHEMBL11701929 | 0.95 | ADORA2B (0.78) | ADORA2BRXFP1MAPK1LMNAMAPT | |
| SCHEMBL11699832 | 0.95 | ADORA2B (0.78) | ADORA2BRXFP1MAPK1LMNAMAPT | |
| SCHEMBL10394216 | 0.95 | ADORA2B (0.78) | ADORA2BRXFP1MAPK1LMNAMAPT | |
| SCHEMBL11702145 | 0.95 | ADORA2B (0.78) | ADORA2BRXFP1MAPK1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170349317-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | THE COCA-COLA COMPANY | 2017-12-07 | — | — | US | disclosed |
| US-20170349317-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | THE COCA-COLA COMPANY | 2017-12-07 | — | — | US | disclosed |
| US-9764872-B2 | Gas barrier enhancing additives and methods | THE COCA-COLA COMPANY (US) | 2017-09-19 | — | — | US | disclosed |
| US-9764872-B2 | Gas barrier enhancing additives and methods | THE COCA-COLA COMPANY (US) | 2017-09-19 | — | — | US | disclosed |
| US-20160031583-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | CSPC INNOVATION PHARMACEUTICAL CO., LTD. (CN) | 2016-02-04 | — | — | US | disclosed |
| US-20160031583-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | CSPC INNOVATION PHARMACEUTICAL CO., LTD. (CN) | 2016-02-04 | — | — | US | disclosed |
| WO-2014152788-A1 | GAS BARRIER ENHANCING ADDITIVES AND METHODS | THE COCA-COLA-COMPANY (US) | 2014-09-25 | — | — | WO | disclosed |